Hyperproinsulinemia

Jump to navigation Jump to search

WikiDoc Resources for Hyperproinsulinemia

Articles

Most recent articles on Hyperproinsulinemia

Most cited articles on Hyperproinsulinemia

Review articles on Hyperproinsulinemia

Articles on Hyperproinsulinemia in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hyperproinsulinemia

Images of Hyperproinsulinemia

Photos of Hyperproinsulinemia

Podcasts & MP3s on Hyperproinsulinemia

Videos on Hyperproinsulinemia

Evidence Based Medicine

Cochrane Collaboration on Hyperproinsulinemia

Bandolier on Hyperproinsulinemia

TRIP on Hyperproinsulinemia

Clinical Trials

Ongoing Trials on Hyperproinsulinemia at Clinical Trials.gov

Trial results on Hyperproinsulinemia

Clinical Trials on Hyperproinsulinemia at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hyperproinsulinemia

NICE Guidance on Hyperproinsulinemia

NHS PRODIGY Guidance

FDA on Hyperproinsulinemia

CDC on Hyperproinsulinemia

Books

Books on Hyperproinsulinemia

News

Hyperproinsulinemia in the news

Be alerted to news on Hyperproinsulinemia

News trends on Hyperproinsulinemia

Commentary

Blogs on Hyperproinsulinemia

Definitions

Definitions of Hyperproinsulinemia

Patient Resources / Community

Patient resources on Hyperproinsulinemia

Discussion groups on Hyperproinsulinemia

Patient Handouts on Hyperproinsulinemia

Directions to Hospitals Treating Hyperproinsulinemia

Risk calculators and risk factors for Hyperproinsulinemia

Healthcare Provider Resources

Symptoms of Hyperproinsulinemia

Causes & Risk Factors for Hyperproinsulinemia

Diagnostic studies for Hyperproinsulinemia

Treatment of Hyperproinsulinemia

Continuing Medical Education (CME)

CME Programs on Hyperproinsulinemia

International

Hyperproinsulinemia en Espanol

Hyperproinsulinemia en Francais

Business

Hyperproinsulinemia in the Marketplace

Patents on Hyperproinsulinemia

Experimental / Informatics

List of terms related to Hyperproinsulinemia

Hyperproinsulinemia is a disease where insulin is not sufficiently processed before secretion and immature forms of insulin make up the majority of circulating insulin immunoreactivity in both fasting and glucose-stimulated conditions (insulin immunoreactivity refers to all molecules detectable by an insulin antibody, i.e. insulin, proinsulin, and proinsulin-like material). The term is composed of hyper - high, proinsulin - immature insulin molecule, and -nemia - disease.

Hyperproinsulinemia is more frequent in type 2 diabetes. It has been attributed to either a direct β-cells defect or an indirect effect of cell dysregulation under sustained elevated blood glucose (hyperglycemia).

Some alleles of insulin can cause hyperproinsulinemia (see table 2: monogenic forms of type 1 diabetes, INS (insulin). For a more detailed descriptions of the insulin gene variations leading to hyperproinsulinemia see NCBI's OMIM 176730 Template:WikiDoc Sources